YUKAI Health Group Statistics
Total Valuation
YKAI has a market cap or net worth of $80.00 million. The enterprise value is $79.83 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
YKAI has 16.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 16.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 85.49.
| PE Ratio | 85.49 |
| Forward PE | n/a |
| PS Ratio | 8.29 |
| Forward PS | n/a |
| PB Ratio | 38.50 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.98 |
| P/OCF Ratio | 25.91 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 50.90, with an EV/FCF ratio of 28.92.
| EV / Earnings | 85.31 |
| EV / Sales | 8.27 |
| EV / EBITDA | 50.90 |
| EV / EBIT | 60.28 |
| EV / FCF | 28.92 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 0.70 |
| Debt / FCF | 0.40 |
| Interest Coverage | 15.38 |
Financial Efficiency
Return on equity (ROE) is 45.04% and return on invested capital (ROIC) is 31.51%.
| Return on Equity (ROE) | 45.04% |
| Return on Assets (ROA) | 21.92% |
| Return on Capital (ROIC) | 31.51% |
| Revenue Per Employee | $104,895 |
| Profits Per Employee | $10,172 |
| Employee Count | 92 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, YKAI has paid $302,538 in taxes.
| Income Tax | 302,538 |
| Effective Tax Rate | 24.43% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, YKAI had revenue of $9.65 million and earned $935,824 in profits. Earnings per share was $0.06.
| Revenue | 9.65M |
| Gross Profit | 2.30M |
| Operating Income | 1.32M |
| Pretax Income | 1.24M |
| Net Income | 935,824 |
| EBITDA | 1.57M |
| EBIT | 1.32M |
| Earnings Per Share (EPS) | $0.06 |
Full Income StatementBalance Sheet
The company has $1.26 million in cash and $1.09 million in debt, giving a net cash position of $165,350 or $0.01 per share.
| Cash & Cash Equivalents | 1.26M |
| Total Debt | 1.09M |
| Net Cash | 165,350 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 2.08M |
| Book Value Per Share | 0.13 |
| Working Capital | 1.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.09 million and capital expenditures -$326,710, giving a free cash flow of $2.76 million.
| Operating Cash Flow | 3.09M |
| Capital Expenditures | -326,710 |
| Free Cash Flow | 2.76M |
| FCF Per Share | $0.17 |
Full Cash Flow StatementMargins
Gross margin is 23.83%, with operating and profit margins of 13.70% and 9.70%.
| Gross Margin | 23.83% |
| Operating Margin | 13.70% |
| Pretax Margin | 12.83% |
| Profit Margin | 9.70% |
| EBITDA Margin | 16.25% |
| EBIT Margin | 13.72% |
| FCF Margin | 28.61% |